Assessing Neurodevelopment in Congenital Heart Disease.

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.

Also called NCT02996630

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02996630
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02996630. Non-randomized; no masking; primary purpose diagnostic. Start 2013-05 (registry gives no type); primary completion 2017-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessing Neurodevelopment in Congenital Heart Disease.
Acronym
NEUROHEART
Condition
Congenital Heart Disease
Intervention (Procedure)
Sonography
Intervention (Device)
Magnetic Resonance Imaging
Intervention (Other)
Bailey Test
Intervention (Procedure)
Surgical intervention
Intervention (Procedure)
Brain monitoring
Intervention (Procedure)
cord blood sample
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute (class: other)
Collaborator
Hospital Sant Joan de Deu (class: other)
Collaborator
Hospital Universitario La Paz (class: other)
Collaborator
Hospital Universitario 12 de Octubre (class: other)
Collaborator
Hospital General Universitario Gregorio Marañon (class: other)
Collaborator
Fundacion Dexeus (class: other)

Record details

Record id
cardio:ct-nct02996630
Content hash
63340561b17e421c2ba4973112c75c7964b8850baac734c83f48a36a7eb8b47d